AP-1 and colorectal cancer
- PMID: 16259733
- DOI: 10.1163/156856005774423935
AP-1 and colorectal cancer
Abstract
Activator protein-1 (AP-1) is a transcription factor that consists of either a Jun-Jun homodimer or a Jun-Fos heterodimer. AP-1 regulates the expression of multiple genes essential for cell proliferation, differentiation and apoptosis. Numerous reports suggest that AP-1 plays an important role in various human diseases. Among them, the roles relating to human cancers have been strongly suggested for a long time. In human cancers, colorectal cancer is still a leading cause of morbidity and mortality in the world. Since there are some reports about the role of AP-1 in colorectal cancer response to a number of stimuli, such as cytokines and growth factors, and oncogenictransformation, therapeutic inhibition of AP-1 activity has attracted considerable interest. Here, we demonstrate the biological properties of AP-1 and its role in colorectal cancer, and discuss a possibility of an AP-1 inhibitor, an adenovirus dominant-negative mutant of c-Jun, as a therapeutic agent for gene therapy.
Similar articles
-
Activation and inhibition of the AP-1 complex in human breast cancer cells.Mol Carcinog. 1996 Mar;15(3):215-26. doi: 10.1002/(SICI)1098-2744(199603)15:3<215::AID-MC7>3.0.CO;2-G. Mol Carcinog. 1996. PMID: 8597534
-
Dominant-negative mutant of c-Jun gene transfer: a novel therapeutic strategy for colorectal cancer.Gene Ther. 2004 Jan;11(2):187-93. doi: 10.1038/sj.gt.3302158. Gene Ther. 2004. PMID: 14712303
-
Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.Oncogene. 1998 May 28;16(21):2711-21. doi: 10.1038/sj.onc.1201798. Oncogene. 1998. PMID: 9652737
-
AP-1 in mouse development and tumorigenesis.Oncogene. 2001 Apr 30;20(19):2401-12. doi: 10.1038/sj.onc.1204389. Oncogene. 2001. PMID: 11402336 Review.
-
AP-1 transcription factor complexes in CNS disorders and development.J Fla Med Assoc. 1995 Aug;82(8):551-4. J Fla Med Assoc. 1995. PMID: 7561734 Review.
Cited by
-
Silencing of CDK2, but not CDK1, separates mitogenic from anti-apoptotic signaling, sensitizing p53 defective cells for synthetic lethality.Cell Cycle. 2016 Dec;15(23):3203-3209. doi: 10.1080/15384101.2016.1241915. Epub 2016 Nov 10. Cell Cycle. 2016. PMID: 27831832 Free PMC article.
-
Crosstalk between Wnt Signaling and RNA Processing in Colorectal Cancer.J Cancer. 2013;4(2):96-103. doi: 10.7150/jca.5470. Epub 2013 Jan 5. J Cancer. 2013. PMID: 23386908 Free PMC article.
-
High expression of Foxp3, IL-23p19 and survivin mRNA in colorectal carcinoma.Int J Colorectal Dis. 2009 Feb;24(2):151-7. doi: 10.1007/s00384-008-0588-8. Epub 2008 Sep 30. Int J Colorectal Dis. 2009. PMID: 18825388
-
Histone Methyltransferase SETDB1 Promotes Immune Evasion in Colorectal Cancer via FOSB-Mediated Downregulation of MicroRNA-22 through BATF3/PD-L1 Pathway.J Immunol Res. 2022 Apr 20;2022:4012920. doi: 10.1155/2022/4012920. eCollection 2022. J Immunol Res. 2022. PMID: 35497876 Free PMC article.
-
COX-2 gene expression in colon cancer tissue related to regulating factors and promoter methylation status.BMC Cancer. 2011 Jun 13;11:238. doi: 10.1186/1471-2407-11-238. BMC Cancer. 2011. PMID: 21668942 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous